Riley Carter
Advisor: Doug Mitchell
Cohort: 2022

Ribosomally-synthesized and post-translationally modified peptides (RiPPs) are a burgeoning group of natural products shown to have antibiotic, anticancer, and analgesic activities. Discovery of new RiPPs has been accelerated by bioinformatic approaches, opening the door for novel medicines and research on new enzymatic reactions. The Mitchell lab is focused on discovering and characterizing new RiPPs and their biosynthetic enzymes, often utilizing bioinformatics. My research is centered on elucidating the function of a novel, bioinformatically predicted protein associated with RiPP biosynthesis.